ID

28339

Descripción

Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines; ODM derived from: https://clinicaltrials.gov/show/NCT01547923

Link

https://clinicaltrials.gov/show/NCT01547923

Palabras clave

Versiones (1)
  1. 5/1/18 5/1/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

5 de enero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Colorectal Cancer NCT01547923

Inglés

Eligibility Colorectal Cancer NCT01547923

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
colorectal cancer, histologically confirmed, with all types included (including adjuvant cases), requiring treatment with intravenous 5-fluorouracil.
Descripción

Colorectal Carcinoma Type All | Adjuvant therapy | 5-Fluorouracil Intravenous Patient need for

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009402
UMLS CUI [1,2]
C0332307
UMLS CUI [1,3]
C0444868
UMLS CUI [2]
C0677850
UMLS CUI [3,1]
C0016360
UMLS CUI [3,2]
C1522726
UMLS CUI [3,3]
C0686904
anterior chemotherapy authorised, with the exception of chemotherapy containing a derivate of 5-fluorouracil
Descripción

Prior Chemotherapy | Exception 5-Fluorouracil Derivative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0016360
UMLS CUI [2,3]
C1527240
age > or = 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
who performance status < or = 2
Descripción

WHO performance status scale

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1298650
haematologic and hepatic parameters : neutrophils > or = 1000 /mm3, platelets > or = 100000/mm3, total bilirubin < or = 2 x uln, ast and alt < or = 3 x uln, apl < or = 5 x uln
Descripción

Hematologic function | Liver function | Neutrophil count | Platelet Count measurement | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0200633
UMLS CUI [4]
C0032181
UMLS CUI [5]
C1278039
UMLS CUI [6]
C0201899
UMLS CUI [7]
C0201836
UMLS CUI [8]
C0201850
complete initial assessment before first treatment administration for imaging and pharmacogenetic, within 15 days for biology, and within 7 days for clinical examination.
Descripción

Initial assessment Complete | Therapeutic procedure First Imaging | Therapeutic procedure First Pharmacogenetic Test | Therapeutic procedure First Test biological | Therapeutic procedure First Clinical examination

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0150637
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0205435
UMLS CUI [2,3]
C0011923
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0205435
UMLS CUI [3,3]
C2347500
UMLS CUI [4,1]
C0087111
UMLS CUI [4,2]
C0205435
UMLS CUI [4,3]
C0039593
UMLS CUI [4,4]
C0205460
UMLS CUI [5,1]
C0087111
UMLS CUI [5,2]
C0205435
UMLS CUI [5,3]
C1456356
signed written informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy with fluoropyrimidines
Descripción

fluoropyrimidine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0596581
symptomatic or uncontrolled ventral nervous system metastases
Descripción

CNS metastases Symptomatic | CNS metastases Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C0686377
UMLS CUI [2,2]
C0205318
psychiatric disease disrupting the trial understanding and the enlightened and voluntary consent character
Descripción

Mental disorder Preventing Comprehension Study Protocol | Mental disorders Preventing Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C1292733
UMLS CUI [1,3]
C0162340
UMLS CUI [1,4]
C2348563
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C1292733
UMLS CUI [2,3]
C0021430
patient who is pregnant or breast feeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
woman not consenting to use adequate contraceptive precautions during the study
Descripción

Gender Contraceptive methods Unwilling

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
patient who can not submit itself to the formal follow-up for psychological, social, family or geographical reasons
Descripción

Follow-up Unsuccessful Due to Psychological Factors | Follow-up Unsuccessful Due to Social factor | Follow-up Unsuccessful Due to Factor Familial | Follow-up Unsuccessful Due to Geographic Factors

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3274571
UMLS CUI [1,2]
C1272705
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C0033898
UMLS CUI [2,1]
C3274571
UMLS CUI [2,2]
C1272705
UMLS CUI [2,3]
C0678226
UMLS CUI [2,4]
C0337460
UMLS CUI [3,1]
C3274571
UMLS CUI [3,2]
C1272705
UMLS CUI [3,3]
C0678226
UMLS CUI [3,4]
C1521761
UMLS CUI [3,5]
C0241888
UMLS CUI [4,1]
C3274571
UMLS CUI [4,2]
C1272705
UMLS CUI [4,3]
C0678226
UMLS CUI [4,4]
C0017444
significant serious pathology or any instable medical condition (cardiac pathology uncontrolled, myocardial infarction within 6 months before enrollment, systemic active uncontrolled infection)
Descripción

Pathology Serious | Medical condition Unstable | Heart Disease Uncontrolled | Myocardial Infarction | Sepsis Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0677042
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0443343
UMLS CUI [3,1]
C0018799
UMLS CUI [3,2]
C0205318
UMLS CUI [4]
C0027051
UMLS CUI [5,1]
C0243026
UMLS CUI [5,2]
C0205318
any investigational agent within 4 weeks before enrollment
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
Volver a la parte superior de la página

Similar models

Eligibility Colorectal Cancer NCT01547923

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Colorectal Carcinoma Type All | Adjuvant therapy | 5-Fluorouracil Intravenous Patient need for
Item
colorectal cancer, histologically confirmed, with all types included (including adjuvant cases), requiring treatment with intravenous 5-fluorouracil.
boolean
C0009402 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C0444868 (UMLS CUI [1,3])
C0677850 (UMLS CUI [2])
C0016360 (UMLS CUI [3,1])
C1522726 (UMLS CUI [3,2])
C0686904 (UMLS CUI [3,3])
Prior Chemotherapy | Exception 5-Fluorouracil Derivative
Item
anterior chemotherapy authorised, with the exception of chemotherapy containing a derivate of 5-fluorouracil
boolean
C1514457 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0016360 (UMLS CUI [2,2])
C1527240 (UMLS CUI [2,3])
Age
Item
age > or = 18 years
boolean
C0001779 (UMLS CUI [1])
WHO performance status scale
Item
who performance status < or = 2
boolean
C1298650 (UMLS CUI [1])
Hematologic function | Liver function | Neutrophil count | Platelet Count measurement | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement
Item
haematologic and hepatic parameters : neutrophils > or = 1000 /mm3, platelets > or = 100000/mm3, total bilirubin < or = 2 x uln, ast and alt < or = 3 x uln, apl < or = 5 x uln
boolean
C0221130 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0200633 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C1278039 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
C0201850 (UMLS CUI [8])
Initial assessment Complete | Therapeutic procedure First Imaging | Therapeutic procedure First Pharmacogenetic Test | Therapeutic procedure First Test biological | Therapeutic procedure First Clinical examination
Item
complete initial assessment before first treatment administration for imaging and pharmacogenetic, within 15 days for biology, and within 7 days for clinical examination.
boolean
C0150637 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0205435 (UMLS CUI [2,2])
C0011923 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C0205435 (UMLS CUI [3,2])
C2347500 (UMLS CUI [3,3])
C0087111 (UMLS CUI [4,1])
C0205435 (UMLS CUI [4,2])
C0039593 (UMLS CUI [4,3])
C0205460 (UMLS CUI [4,4])
C0087111 (UMLS CUI [5,1])
C0205435 (UMLS CUI [5,2])
C1456356 (UMLS CUI [5,3])
Informed Consent
Item
signed written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
fluoropyrimidine
Item
prior chemotherapy with fluoropyrimidines
boolean
C0596581 (UMLS CUI [1])
CNS metastases Symptomatic | CNS metastases Uncontrolled
Item
symptomatic or uncontrolled ventral nervous system metastases
boolean
C0686377 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0686377 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Mental disorder Preventing Comprehension Study Protocol | Mental disorders Preventing Informed Consent
Item
psychiatric disease disrupting the trial understanding and the enlightened and voluntary consent character
boolean
C0004936 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
C0004936 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
patient who is pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Gender Contraceptive methods Unwilling
Item
woman not consenting to use adequate contraceptive precautions during the study
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
Follow-up Unsuccessful Due to Psychological Factors | Follow-up Unsuccessful Due to Social factor | Follow-up Unsuccessful Due to Factor Familial | Follow-up Unsuccessful Due to Geographic Factors
Item
patient who can not submit itself to the formal follow-up for psychological, social, family or geographical reasons
boolean
C3274571 (UMLS CUI [1,1])
C1272705 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0033898 (UMLS CUI [1,4])
C3274571 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
C0678226 (UMLS CUI [2,3])
C0337460 (UMLS CUI [2,4])
C3274571 (UMLS CUI [3,1])
C1272705 (UMLS CUI [3,2])
C0678226 (UMLS CUI [3,3])
C1521761 (UMLS CUI [3,4])
C0241888 (UMLS CUI [3,5])
C3274571 (UMLS CUI [4,1])
C1272705 (UMLS CUI [4,2])
C0678226 (UMLS CUI [4,3])
C0017444 (UMLS CUI [4,4])
Pathology Serious | Medical condition Unstable | Heart Disease Uncontrolled | Myocardial Infarction | Sepsis Uncontrolled
Item
significant serious pathology or any instable medical condition (cardiac pathology uncontrolled, myocardial infarction within 6 months before enrollment, systemic active uncontrolled infection)
boolean
C0677042 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0018799 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0027051 (UMLS CUI [4])
C0243026 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
Investigational New Drugs
Item
any investigational agent within 4 weeks before enrollment
boolean
C0013230 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial